Anticancer Potential of Sanguinarine for Various Human Malignancies
- 21 June 2017
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 9 (9) , 933-950
Abstract
Sanguinarine (Sang) – a benzophenanthridine alkaloid extracted from Sanguinaria canadensis – exhibits antioxidant, anti-inflammatory, proapoptotic and growth inhibitory activities on tumor cells of various cancer types as established by in vivo and in vitro studies. Although the underlying mechanism of Sang antitumor activity is yet to be fully elucidated, Sang has displayed multiple biological effects, which remain to suggest its possible use in plant-derived treatments of human malignancies. This review covers the anticancer abilities of Sang including inhibition of aberrantly activated signal transduction pathways, induction of cell death and inhibition of cancer cell proliferation. It also highlights Sang-mediated inhibition of angiogenesis, inducing the expression of tumor suppressors, sensitization of cancer cells to standard chemotherapeutics to enhance their cytotoxic effects, while addressing the present need for further pharmacokinetic-based studies.Keywords
Funding Information
- Medical Research Center (16354/16)
This publication has 101 references indexed in Scilit:
- Apoptosis Induction of Human Bladder Cancer Cells by Sanguinarine through Reactive Oxygen Species-Mediated Up-Regulation of Early Growth Response Gene-1PLOS ONE, 2013
- Sanguinarine Inhibits Vascular Endothelial Growth Factor Release by Generation of Reactive Oxygen Species in MCF-7 Human Mammary Adenocarcinoma CellsBioMed Research International, 2013
- P-glycoprotein Inhibition for Optimal Drug DeliveryDrug Target Insights, 2013
- Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in anin vivorat modelExperimental & Molecular Medicine, 2012
- Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathwaysBiochemical and Biophysical Research Communications, 2010
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology and Medicine, 2010
- Sanguinarine Suppresses Prostate Tumor Growth and Inhibits Survivin ExpressionGenes & Cancer, 2010
- Small molecules and targeted therapies in distant metastatic diseaseAnnals of Oncology, 2009
- Directing cancer cells to self-destruct with pro-apoptotic receptor agonistsNature Reviews Drug Discovery, 2008
- Chelerythrine and Sanguinarine Dock at Distinct Sites on BclXL that are Not the Classic BH3 Binding CleftJournal of Molecular Biology, 2006